Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials

International Journal of Radiation Oncology, Biology, Physics
Reiko ImaiWorking Group for Bone and Soft Tissue Sarcomas

Abstract

To summarize the results of treatment for sacral chordoma in Phase I-II and Phase II carbon ion radiotherapy trials for bone and soft-tissue sarcomas. We performed a retrospective analysis of 38 patients with medically unresectable sacral chordomas treated with the Heavy Ion Medical Accelerator in Chiba, Japan between 1996 and 2003. Of the 38 patients, 30 had not received previous treatment and 8 had locally recurrent tumor after previous resection. The applied carbon ion dose was 52.8-73.6 Gray equivalents (median, 70.4) in a total of 16 fixed fractions within 4 weeks. The median patient age was 66 years. The cranial tumor extension was S2 or greater in 31 patients. The median clinical target volume was 523 cm(3). The median follow-up period was 80 months. The 5-year overall survival rate was 86%, and the 5-year local control rate was 89%. After treatment, 27 of 30 patients with primary tumor remained ambulatory with or without supportive devices. Two patients experienced severe skin or soft-tissue complications requiring skin grafts. Carbon ion radiotherapy appears effective and safe in the treatment of patients with sacral chordoma and offers a promising alternative to surgery.

References

Mar 1, 1979·Journal of Neurosurgery·N SundaresanA G Huvos
Mar 1, 1986·Radiology·B E AmendolaK D McClatchey
Jun 1, 1984·Cancer·T E KaiserK K Unni
Mar 30, 1995·International Journal of Radiation Oncology, Biology, Physics·J D CoxT F Pajak
May 20, 1993·International Journal of Radiation Oncology, Biology, Physics·R SchoenthalerT L Phillips
Oct 1, 1996·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C CattonJ Wunder
Apr 1, 1997·Journal of Surgical Oncology·T OzakiW Winkelmann
Mar 26, 1999·Cancer·T YonemotoH Moriya
Apr 29, 1999·International Journal of Radiation Oncology, Biology, Physics·T KanaiK Kawachi
Jun 15, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·T KamadaT Kanai
Jun 23, 2000·International Journal of Radiation Oncology, Biology, Physics·S MinoharaM Kanazawa
Nov 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tadashi KamadaUNKNOWN Working Group for the Bone and Soft Tissue Sarcomas
Jan 31, 2004·International Journal of Radiation Oncology, Biology, Physics·Daniela Schulz-ErtnerJürgen Debus
Sep 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Reiko ImaiUNKNOWN Working Group for Bone, Soft Tissue Sarcomas
Jul 5, 2005·International Journal of Radiation Oncology, Biology, Physics·Richard S PietersJohn E Munzenrider
Jun 8, 2006·International Journal of Radiation Oncology, Biology, Physics·Lily ParkHerman D Suit
Nov 7, 2006·International Journal of Radiation Oncology, Biology, Physics·Hans Peter RutzGudrun Goitein
Dec 20, 2008·International Journal of Radiation Oncology, Biology, Physics·Thomas F DeLaneyFrancis J Hornicek

❮ Previous
Next ❯

Citations

Sep 7, 2013·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·J-L HabrandR Dendale
May 22, 2013·Nature Reviews. Clinical Oncology·Jay S Loeffler, Marco Durante
Jul 17, 2012·Japanese Journal of Clinical Oncology·Hirohiko Tsujii, Tadashi Kamada
Apr 17, 2013·Radiation Oncology·Hiroshi FujisawaTakamitsu A Kato
Apr 1, 2014·Radiation Oncology·Cody D SchlaffKevin A Camphausen
Mar 19, 2014·La Radiologia medica·Jeffrey TuanRoberto Orecchia
Mar 24, 2011·The British Journal of Radiology·R ImaiH Tsujii
Nov 19, 2013·Current Problems in Cancer·Virag DandekarPaul M Kent
Oct 4, 2015·Clinical Neurology and Neurosurgery·Ming-Xiang ZouYou-Wen Deng
Feb 24, 2012·Cancer·Akira MatsunobuUNKNOWN Working Group for Bone and Soft Tissue Sarcomas
Oct 1, 2011·Cancer Science·Hiroki ShiratoKikuo Umegaki
Apr 17, 2016·International Journal of Radiation Oncology, Biology, Physics·Daniel J IndelicatoWilliam M Mendenhall
Apr 17, 2016·International Journal of Radiation Oncology, Biology, Physics·Reiko ImaiUNKNOWN Working Group for Bone and Soft Tissue Sarcomas
Apr 28, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Masashi KotoHirohiko Tsujii
Sep 28, 2016·Frontiers in Oncology·Esther YuTimothy J Kinsella
Oct 22, 2016·Journal of Surgical Oncology·Karen De Amorim Bernstein, Thomas DeLaney
Jun 5, 2016·Technology in Cancer Research & Treatment·Edward W JungSamuel T Chao
Jan 21, 2017·F1000Research·Carl YoussefCarlos A Bagley
Dec 1, 2018·Journal of Neurosurgery. Spine·Nicolas DeaUNKNOWN AOSpine Knowledge Forum Tumor
Oct 12, 2012·International Journal of Clinical Oncology·Shintaro IwataShin-Ichiro Tatezaki
Jul 21, 2011·Neurosurgery·Hormuzdiyar H DasenbrockJean-Paul Wolinsky
Oct 1, 2016·International Journal of Particle Therapy·Niloy R DattaDamien C Weber
Mar 30, 2017·Neurosurgery·Nicolas DeaCharles Fisher
Sep 18, 2020·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Yusuke DemizuUNKNOWN Japan Carbon-Ion Radiation Oncology Study Group
Nov 9, 2010·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Angelika Zabel-du BoisStefanie Milker-Zabel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.